KYTX Earnings

Quarterly EPS
$-0.80
Q3 2024
$-0.87
Q4 2024
$-1.03
Q1 2025
$-0.97
Q2 2025
$-0.85
Q3 2025
$-0.80
Q4 2025
$-0.66
Q1 2026
$-0.63
Q2 2026
Latest RevenueN/A
Latest Net Income-38319000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.630-38319000+35.1%
Q1 2026-$0.660-39728000+35.9%
Q4 2025-$0.800-37804000+8.0%
Q3 2025-$0.850-36787000-6.2%
Q2 2025-$0.970-42081000-44.8%
Q1 2025-$1.030-44635000+8.0%
Q4 2024-$0.870-37489000
Q3 2024-$0.800-34492000
Q2 2024-$0.670-28803000
Q1 2024-$1.120-26693000
Kyverna Therapeutics (KYTX) — Earnings